If this patient discontinues growth hormone therapy, over time, he could become fatigued and weak again
Women over 50 are among the most common GHK-Cu users, as natural levels of the peptide decline with age
It is about having a provider who can assess whether the compound is working, whether the dose is appropriate for the specific injury and patient profile, and whether the response at weeks four and eight warrants continuing, adjusting, or pausing
These clinical studies indicate that a topical product containing GHK-Cu may be administered for 4-12 weeks to improve the appearance, texture, and health of the skin
Long-term (months to years), the freezer at -20 degrees Celsius preserves potency best